Salpingectomy to prevent ovarian cancer: A Countercurrents Series.
作者信息
Narod S A
出版信息
Curr Oncol. 2013 Jun;20(3):145-7. doi: 10.3747/co.20.1471.
Abstract
摘要
相似文献
1
Salpingectomy to prevent ovarian cancer: A Countercurrents Series.
Curr Oncol. 2013 Jun;20(3):145-7. doi: 10.3747/co.20.1471.
2
Current Updates on Salpingectomy for the Prevention of Ovarian Cancer and Its Practice Patterns Worldwide.
Chin Med Sci J. 2017 Sep 27;32(3):185-192. doi: 10.24920/J1001-9294.2017.022.
3
Perceptions of risk and reward in BRCA1 and BRCA2 mutation carriers choosing salpingectomy for ovarian cancer prevention.
Fam Cancer. 2020 Apr;19(2):143-151. doi: 10.1007/s10689-020-00166-5. Epub 2020 Feb 24.
4
Risks and benefits of opportunistic salpingectomy during vaginal hysterectomy: a decision analysis.
Am J Obstet Gynecol. 2017 Nov;217(5):603.e1-603.e6. doi: 10.1016/j.ajog.2017.06.007. Epub 2017 Jun 12.
5
The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States.
Am J Obstet Gynecol. 2020 Nov;223(5):721.e1-721.e18. doi: 10.1016/j.ajog.2020.04.028. Epub 2020 Apr 30.
6
Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
Am J Obstet Gynecol. 2019 Jan;220(1):106.e1-106.e10. doi: 10.1016/j.ajog.2018.08.032. Epub 2018 Aug 28.
7
Salpingectomy to reduce risk of ovarian cancer in women at average risk.
Menopause. 2019 Sep;26(9):1059-1061. doi: 10.1097/GME.0000000000001407.
8
Salpingectomy and Ovarian Cancer Prevention.
Nurs Womens Health. 2015;19(6):543-9. doi: 10.1111/1751-486X.12250.
9
Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement.
Maturitas. 2017 Jun;100:86-91. doi: 10.1016/j.maturitas.2017.03.003. Epub 2017 Mar 15.
10
Prophylactic salpingectomy for the prevention of ovarian cancer: Who should we target?
Int J Cancer. 2020 Sep 1;147(5):1245-1251. doi: 10.1002/ijc.32916. Epub 2020 Feb 29.
引用本文的文献
1
Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic Review.
JAMA Surg. 2023 Nov 1;158(11):1204-1211. doi: 10.1001/jamasurg.2023.4164.
2
Hysterectomy with opportunistic salpingectomy versus hysterectomy alone.
Cochrane Database Syst Rev. 2019 Aug 28;8(8):CD012858. doi: 10.1002/14651858.CD012858.pub2.
3
Cell Origins of High-Grade Serous Ovarian Cancer.
Cancers (Basel). 2018 Nov 12;10(11):433. doi: 10.3390/cancers10110433.
4
Opportunistic salpingectomy: Remove the tubes and save the ovaries.
J Midlife Health. 2016 Oct-Dec;7(4):153. doi: 10.4103/0976-7800.195691.
5
Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for Prevention.
Front Oncol. 2016 May 2;6:108. doi: 10.3389/fonc.2016.00108. eCollection 2016.
6
It's Totally Tubular....Riding The New Wave of Ovarian Cancer Research.
Cancer Res. 2016 Jan 1;76(1):10-7. doi: 10.1158/0008-5472.CAN-15-1382. Epub 2015 Dec 15.
7
Major clinical research advances in gynecologic cancer in 2014.
J Gynecol Oncol. 2015 Apr;26(2):156-67. doi: 10.3802/jgo.2015.26.2.156.
8
Ovarian cancer risk reduction through opportunistic salpingectomy.
J Gynecol Oncol. 2015 Apr;26(2):83-6. doi: 10.3802/jgo.2015.26.2.83.
9
Occult tubal carcinoma found at risk reducing salpingectomy in a BRCA1 carrier.
Gynecol Oncol Case Rep. 2014 Apr 2;9:1-2. doi: 10.1016/j.gynor.2014.03.003. eCollection 2014 Aug.
10
Preventing ovarian cancer by salpingectomy.
Curr Oncol. 2013 Jun;20(3):139-42. doi: 10.3747/co.20.1613.
本文引用的文献
1
Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1089-96. doi: 10.1158/1055-9965.EPI-12-0201. Epub 2012 May 7.
2
Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.
J Natl Cancer Inst. 2008 Oct 1;100(19):1361-7. doi: 10.1093/jnci/djn313. Epub 2008 Sep 23.
3
Ovarian cancer and hormone replacement therapy in the Million Women Study.
Lancet. 2007 May 19;369(9574):1703-10. doi: 10.1016/S0140-6736(07)60534-0.
4
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
JAMA. 2006 Jul 12;296(2):185-92. doi: 10.1001/jama.296.2.185.
5
Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.
J Clin Oncol. 2005 Oct 20;23(30):7491-6. doi: 10.1200/JCO.2004.00.7138.
6
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
Am J Hum Genet. 2003 May;72(5):1117-30. doi: 10.1086/375033. Epub 2003 Apr 3.
7
Cancer incidence in a population of Jewish women at risk of ovarian cancer.
J Clin Oncol. 2002 Mar 15;20(6):1570-7. doi: 10.1200/JCO.2002.20.6.1570.
8
Epidemiology and primary prevention of cancers of the breast, endometrium, and ovary. A brief overview.
Ann Epidemiol. 1994 Mar;4(2):89-95. doi: 10.1016/1047-2797(94)90052-3.
Zotero 插件